[go: up one dir, main page]

AR063366A1 - Suspensiones farmaceuticas acuosas que contienen rebamipide y su proceso de fabricacion - Google Patents

Suspensiones farmaceuticas acuosas que contienen rebamipide y su proceso de fabricacion

Info

Publication number
AR063366A1
AR063366A1 ARP070104698A ARP070104698A AR063366A1 AR 063366 A1 AR063366 A1 AR 063366A1 AR P070104698 A ARP070104698 A AR P070104698A AR P070104698 A ARP070104698 A AR P070104698A AR 063366 A1 AR063366 A1 AR 063366A1
Authority
AR
Argentina
Prior art keywords
rebamipide
manufacturing process
containing rebamipide
pharmaceutical suspensions
waterproof containing
Prior art date
Application number
ARP070104698A
Other languages
English (en)
Inventor
Masuda Yoshito
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR063366A1 publication Critical patent/AR063366A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Suspension farmacéutica acuosa que contiene rebamipide que se puede preparar por un proceso simple y mantener el estado de partículas finas dispersas de rebamipide estable sin presentar aglutinacion de las partículas finas. La suspension farmacéutica acuosa que contiene rebamipide de la presente se prepara por mezclado de alcohol polivinílico y además un compuesto que es un compuesto de tipo sal sodica con rebamipide.
ARP070104698A 2006-10-26 2007-10-24 Suspensiones farmaceuticas acuosas que contienen rebamipide y su proceso de fabricacion AR063366A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006291535 2006-10-26

Publications (1)

Publication Number Publication Date
AR063366A1 true AR063366A1 (es) 2009-01-21

Family

ID=39324676

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104698A AR063366A1 (es) 2006-10-26 2007-10-24 Suspensiones farmaceuticas acuosas que contienen rebamipide y su proceso de fabricacion

Country Status (20)

Country Link
US (1) US8772317B2 (es)
EP (1) EP2077840A4 (es)
JP (1) JP5250551B2 (es)
KR (2) KR101491965B1 (es)
CN (1) CN101528229B (es)
AR (1) AR063366A1 (es)
AU (1) AU2007309968B2 (es)
BR (1) BRPI0718429A2 (es)
CA (1) CA2665024C (es)
HK (1) HK1133188A1 (es)
IL (1) IL197950A0 (es)
MX (1) MX2009004433A (es)
MY (1) MY148303A (es)
NZ (1) NZ576224A (es)
RU (1) RU2467751C2 (es)
SG (1) SG175628A1 (es)
TW (1) TWI415629B (es)
UA (1) UA95989C2 (es)
WO (1) WO2008050896A1 (es)
ZA (1) ZA200902778B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
AU2009261101B2 (en) * 2008-06-19 2013-11-07 Otsuka Pharmaceutical Co., Ltd. A pharmaceutical composition comprising rebamipide
US20140010882A1 (en) * 2011-03-24 2014-01-09 Takakuni Matsuda Pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
CN102240260B (zh) * 2011-05-17 2012-05-23 山东省医疗器械研究所 一种治疗阴道干涩症的药物及其制备方法
TW201322982A (zh) 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
ES2652136T3 (es) * 2012-02-16 2018-01-31 Atyr Pharma, Inc. Histidil-tRNA sintetasas para tratar enfermedades autoinmunitarias e inflamatorias
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
TW201536287A (zh) * 2013-09-05 2015-10-01 Otsuka Pharma Co Ltd 瑞巴派特的局部止血用途
CN104586762A (zh) * 2014-04-11 2015-05-06 广州仁恒医药科技有限公司 含有瑞巴派特的药物组合物及其制备方法
CN103976946A (zh) * 2014-05-20 2014-08-13 广州艾格生物科技有限公司 一种含有水溶性高分子聚合物的瑞巴派特混悬滴眼液及其制备方法
JP6854587B2 (ja) * 2015-04-17 2021-04-07 ロート製薬株式会社 医薬製剤
JP7324566B2 (ja) * 2015-05-28 2023-08-10 ロート製薬株式会社 水性眼科組成物
CN105147606A (zh) * 2015-08-18 2015-12-16 广州仁恒医药科技有限公司 一种瑞巴派特水悬浮液的制备方法
KR101718733B1 (ko) 2015-08-21 2017-03-22 국제약품 주식회사 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
JP2017109996A (ja) * 2015-12-11 2017-06-22 日本合成化学工業株式会社 結晶成長抑制剤
CN107349181B (zh) * 2016-05-09 2021-02-19 四川科伦药物研究院有限公司 含有瑞巴派特和聚维酮的眼科水悬浮液及其制备方法
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20200019451A (ko) 2018-08-14 2020-02-24 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR102659338B1 (ko) 2023-05-18 2024-04-19 국제약품 주식회사 안구건조증 치료용 약제학적 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856173D1 (de) * 1987-10-21 1998-06-10 Siemens Ag Verfahren zum Herstellen eines Bipolartransistors mit isolierter Gateelektrode
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
CA2083842A1 (en) * 1991-03-27 1992-09-28 Hisayuki Nakayama Method for preparation of an aqueous suspension
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
AU684115B2 (en) 1993-12-27 1997-12-04 Mitsubishi Chemical Corporation Ophthalmic suspension containing diflupredonate
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
US5576311A (en) 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
AR004214A1 (es) 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP0995435B1 (en) 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
JP3402195B2 (ja) * 1997-05-14 2003-04-28 千寿製薬株式会社 再分散性の良い水性懸濁液剤
WO2002102414A1 (en) * 2001-06-14 2002-12-27 Otsuka Pharmaceutical Co., Ltd. Medicinal compositions
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
JP2005008625A (ja) 2003-05-23 2005-01-13 Santen Pharmaceut Co Ltd キノロン系抗菌化合物を含有する点眼液
EP1627637A1 (en) 2003-05-23 2006-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic solution containing quinolone antimicrobial compound
TW200613006A (en) 2004-09-10 2006-05-01 Otsuka Pharma Co Ltd Rebamipide preparation for rectal administration to be prepared before using
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof

Also Published As

Publication number Publication date
US20100029714A1 (en) 2010-02-04
KR20090073248A (ko) 2009-07-02
IL197950A0 (en) 2009-12-24
CA2665024A1 (en) 2008-05-02
BRPI0718429A2 (pt) 2013-11-12
HK1133188A1 (en) 2010-03-19
TW200822936A (en) 2008-06-01
CN101528229A (zh) 2009-09-09
WO2008050896A1 (en) 2008-05-02
AU2007309968B2 (en) 2012-09-06
KR101491965B1 (ko) 2015-02-10
CA2665024C (en) 2015-04-07
JP2010507566A (ja) 2010-03-11
TWI415629B (zh) 2013-11-21
ZA200902778B (en) 2010-02-24
RU2467751C2 (ru) 2012-11-27
JP5250551B2 (ja) 2013-07-31
CN101528229B (zh) 2012-07-04
EP2077840A4 (en) 2010-08-11
MX2009004433A (es) 2009-05-08
EP2077840A1 (en) 2009-07-15
SG175628A1 (en) 2011-11-28
AU2007309968A1 (en) 2008-05-02
RU2009119717A (ru) 2010-12-10
KR20140088228A (ko) 2014-07-09
MY148303A (en) 2013-03-29
US8772317B2 (en) 2014-07-08
NZ576224A (en) 2010-12-24
UA95989C2 (uk) 2011-09-26

Similar Documents

Publication Publication Date Title
AR063366A1 (es) Suspensiones farmaceuticas acuosas que contienen rebamipide y su proceso de fabricacion
PE20191796A1 (es) Composicion farmaceutica de clorhidrato de s-ketamina
CL2007001613A1 (es) Compuesto de particulas colorantes y/o de carga organica, recubiertas parcialmente con una composicion que contiene particulas de dolomita y ligante; procedimiento para preparar el compuesto, suspension acuosa; uso del compuesto; ayuvante de filtraci
AR073485A1 (es) Composiciones nutricionales con globulos lipidicos de gran tamano
BR112015014831A2 (pt) partículas anidras de pó a líquido
CO6680609A2 (es) Composición acuosa que contiene bromhexina
WO2015021066A3 (en) Electric lighting devices
CL2012001966A1 (es) Formulación farmacéutica que comprende entre 100-150 mg/ml de un anticuerpo que se une específicamente al receptor a de il-17 humana, una solución acuosa de un buffer 5-30 mm de ácido glutámico ph 4,5-5,2, prolina 2-4% p/v y polisorbato-20 0,005-0,02% p/v; envase farmacéutico y kit que comprende dicha formulación; y su uso para tratar psoriasis.
CL2007001612A1 (es) Compuesto de particulas colorantes y/o de carga organica, recubiertas parcialmente con una composicion que contiene carbonato de calcio y ligante; procedimiento para preparar el compuesto; suspension acuosa; uso del compuesto; ayuvante de filtracion;
AR069899A1 (es) Compuestos quimicos derivados de pirazol-triazina
EA201390164A1 (ru) Водная суспензия аморфного кремнезема и способ ее производства
EP2796925A3 (en) A pellicle and an assembly of photomask plus pellicle
CO6280502A2 (es) Una composicion farmaceutica
CL2015000078A1 (es) Composicion de silicato de zirconio microporoso, con un tamaño de particula mayor a 3 micrones y menos de un 7% menor que 3 micrones, con sodio menos al 12% en peso y cationes divalentes de 1-100ppm; y su uso para el tratamiento de hipercalemia en pacientes hipercalemicos
CY1109320T1 (el) Σκευασμα εναιωρηματος φεξοφεναδινης
AR096773A1 (es) Formulación líquida estable
AR096705A1 (es) Composición que comprende ácido glutámico-n,n-diacetato (glda), agua y enzima
BR112013033455A2 (pt) fluido dielétrico e dispositivo
MX2012000103A (es) Nuevos derivados de 1,2,3,4-tetrahidro-pirimido (1,2-a) pirimidin-6-ona, su preparacion y su uso farmaceutica.
MX2012000097A (es) Nuevos derivados de 2,3-dihidro-1h-imidazo {1,2-a} pirimidin-5-ona, su preparacion y su uso en farmaceutica.
BR112014007080A2 (pt) bucha para uso no fornecimento de proteção contra efeitos eletromagnéticos
RS53408B (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION
AR089427A1 (es) Proceso para preparar suspensiones de carbonato de calcio
AR059054A1 (es) Variante d3n de glicosilacion fsh novedosa
AR063597A1 (es) Nueva sal

Legal Events

Date Code Title Description
FB Suspension of granting procedure